Standard
Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial. / Aaboe, K.; Knop, F.K.; Vilsbøll, Tina; Deacon, Carolyn F.; Holst, Jens Juul; Madsbad, S.; Krarup, T.
In:
Diabetologia, 2009, p. 748.
Research output: Contribution to journal › Conference abstract in journal › Research
Harvard
Aaboe, K, Knop, FK, Vilsbøll, T, Deacon, CF, Holst, JJ, Madsbad, S & Krarup, T 2009, 'Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial', Diabetologia, pp. 748.
APA
Aaboe, K., Knop, F. K., Vilsbøll, T., Deacon, C. F., Holst, J. J., Madsbad, S., & Krarup, T. (2009). Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial. Diabetologia, 748.
Vancouver
Aaboe K, Knop FK, Vilsbøll T, Deacon CF, Holst JJ, Madsbad S et al. Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial. Diabetologia. 2009;748.
Author
Aaboe, K. ; Knop, F.K. ; Vilsbøll, Tina ; Deacon, Carolyn F. ; Holst, Jens Juul ; Madsbad, S. ; Krarup, T. / Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial. In: Diabetologia. 2009 ; pp. 748.
Bibtex
@article{03aa9380af7111df825b000ea68e967b,
title = "Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial",
author = "K. Aaboe and F.K. Knop and Tina Vilsb{\o}ll and Deacon, {Carolyn F.} and Holst, {Jens Juul} and S. Madsbad and T. Krarup",
note = "JSEPSuppl. 1 Udgivelsesdato: 2009 Volumne: 52; Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial ; Conference date: 29-11-2010",
year = "2009",
language = "English",
pages = "748",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
}
RIS
TY - ABST
T1 - Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial
AU - Aaboe, K.
AU - Knop, F.K.
AU - Vilsbøll, Tina
AU - Deacon, Carolyn F.
AU - Holst, Jens Juul
AU - Madsbad, S.
AU - Krarup, T.
N1 - JSEPSuppl. 1
Udgivelsesdato: 2009
Volumne: 52
PY - 2009
Y1 - 2009
M3 - Conference abstract in journal
SP - 748
JO - Diabetologia
JF - Diabetologia
SN - 0012-186X
T2 - Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial
Y2 - 29 November 2010
ER -
